SMAIO SA
PAR:ALSMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (8.4), the stock would be worth €-0.48 (106% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -135.4 | €7.7 |
0%
|
| Industry Average | 8.4 | €-0.48 |
-106%
|
| Country Average | 9.9 | €-0.57 |
-107%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| FR |
S
|
SMAIO SA
PAR:ALSMA
|
43.4m EUR | -135.4 | -23.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 16.9 | 25.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 50.9 | 56.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 27 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 17.1 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 21.5 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.9B EUR | 16.5 | 20.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 26.5 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 38.7 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 17.9 | 25.4 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 19.1 | 15.8 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 6.5 |
| Median | 9.9 |
| 70th Percentile | 15.7 |
| Max | 2 301.8 |
Other Multiples
SMAIO SA
Glance View
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 30 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software,
